Raymond James Financial’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$230K	Sell	111,222 -25,000	-18%	-$51.8K	﹤0.01%	4411
2025 Q1	$300K	Buy	136,222 +500	+0.4%	+$1.1K	﹤0.01%	4188
2024 Q4	$208K	Buy	+135,722	New	+$208K	﹤0.01%	4360